Home Page | IBRANCE® (palbociclib) | Safety Info
WebBe in. your moment. Thousands of women living with metastatic breast cancer (mBC) are living in the moment—and taking IBRANCE®. IBRANCE is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC. Learn More.
palbociclib | Apotheek.nl
WebPalbociclib remt de groei van kankercellen. Hierdoor kunnen tumoren niet verder groeien. Bij borstkanker die gevoelig is voor hormonen. De capsule heel doorslikken met een half glas water. Niet kauwen of open maken. Pas op met grapefruit. Eet of …
Palbociclib - Wikipedia
WebPalbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 .
Ibrance® | Pfizer
WebIbrance is een geneesmiddel tegen kanker dat de werkzame stof palbociclib bevat. Ibrance wordt gebruikt voor de behandeling van bepaalde typen borstkanker die gevorderd of uitgezaaid zijn. Dat wil zeggen dat de kanker buiten de oorspronkelijke tumor groeit of zich naar andere organen heeft verspreid. Lees hier meer over borstkanker of ga naar ...
palbociclib - Farmacotherapeutisch Kompas
Webpalbociclib vergelijken met een ander geneesmiddel.. Advies. Zie voor de adviezen van de commissie BOM over palbociclib bij mammacarcinoom nvmo.org.. Zie voor de behandeling van borstkanker de geldende behandelrichtlijn op richtlijnendatabase.nl.. ZIN-rapport 2017 palbociclib Ibrance® hormoonreceptor-positieve, HER2-negatieve gevorderde of …
Ibrance: Uses, Dosage, Side Effects & Warnings - Drugs.com
WebApr 24, 2024 · Ibrance is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Ibrance is used in men and women to treat HR-positive, HER2-negative breast cancer that has spread to other parts of the body.
About IBRANCE® (palbociclib) For mBC | Safety Info
WebA Scientific Advancement In The Treatment Of HR+, HER2- Metastatic Breast Cancer. IBRANCE® IS THE FIRST FDA-APPROVED MEDICATION in its class. IBRANCE is a targeted therapy known as a CDK 4/6 inhibitor . It is not a traditional chemotherapy.
Ibrance | European Medicines Agency
WebOverview. Ibrance is a cancer medicine used to treat breast cancer when the cancer is locally advanced (has spread nearby) or metastatic (has spread to other parts of the body). Ibrance can only be used when the cancer cells have receptors (targets) for certain hormones on their surface (HR-positive) and do not produce abnormally large ...
IBRANCE® capsules - Pfizer Medical Information
WebIBRANCE® capsules (palbociclib) medication page for patients to search for scientific information on Pfizer medications. Also, find the prescribing information, announcements, resources, and channels to connect with Pfizer Medical Information.
Ibrance (Palbociclib): Side Effects, How it Works, and More
WebLearn how Ibrance is used to treat advanced-stage or metastatic, hormone receptor-positive, HER2-negative breast cancer and what its side effects are.
Skip to content